Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) hit a new 52-week low during mid-day trading on Monday. The company traded as low as C$0.07 and last traded at C$0.07, with a volume of 14,052 shares traded. The stock had previously closed at C$0.07.
VentriPoint Diagnostics Price Performance
The stock has a 50 day moving average of C$0.08 and a 200-day moving average of C$0.11. The company has a debt-to-equity ratio of -68.25, a quick ratio of 6.67 and a current ratio of 0.12. The company has a market cap of C$12.65 million, a PE ratio of -3.25 and a beta of -1.31.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
